– Using ProMagen™ in combination with standard chemicals or other biological solutions demonstrated more efficient…
– Using ProMagen™ in combination with standard chemicals or other biological solutions demonstrated more efficient…
20 June 2023 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Appeal of Delisting Determination Biodexa Pharmaceuticals…
20 June 2023 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Appeal of Delisting Determination Biodexa Pharmaceuticals…
FLORHAM PARK, N.J., June 20, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corp. (NASDAQ: PDSB), a…
FLORHAM PARK, N.J., June 20, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corp. (NASDAQ: PDSB), a…
Dr. Brun also appointed as Chairperson of Jasper Research and Development Committee and to Compensation…
Dr. Brun also appointed as Chairperson of Jasper Research and Development Committee and to Compensation…
Presentations highlight efzofitimod’s novel myeloid-cell focused mechanism and current Phase 3 EFZO-FIT™ study in pulmonary…
Presentations highlight efzofitimod’s novel myeloid-cell focused mechanism and current Phase 3 EFZO-FIT™ study in pulmonary…
NEW YORK, June 20, 2023 (GLOBE NEWSWIRE) — LifeMD, Inc. (Nasdaq: LFMD), a leading provider…
NEW YORK, June 20, 2023 (GLOBE NEWSWIRE) — LifeMD, Inc. (Nasdaq: LFMD), a leading provider…
Fort Lee, NJ , June 20, 2023 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (NASDAQ: NVCT)…
Fort Lee, NJ , June 20, 2023 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (NASDAQ: NVCT)…
Single Agent Envafolimab ORR Exceeded Futility Rule that will be Applied at the Interim Efficacy…
Single Agent Envafolimab ORR Exceeded Futility Rule that will be Applied at the Interim Efficacy…
SEATTLE, June 20, 2023 (GLOBE NEWSWIRE) — ShapeTX, the programmable medicine company using AI and…
SEATTLE, June 20, 2023 (GLOBE NEWSWIRE) — ShapeTX, the programmable medicine company using AI and…
–Grant supports the continued preclinical development of AX-5006, a small molecule, gut-restricted amyloid inhibitor for…
–Grant supports the continued preclinical development of AX-5006, a small molecule, gut-restricted amyloid inhibitor for…